Newly-prequalified active pharmaceutical ingredient (API)
Levofloxacin manufactured by Shangyu Jingxin Pharmaceutical Co Ltd has been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API prequalification procedure.
3 products newly prequalified
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
Second diethylcarbamazine prequalified
WHO Prequalification Team - Medicines (PQT) added the below new product to its prequalified list:
Newly-prequalified active pharmaceutical ingredients (APIs)
Lumefantrine manufactured by Micro Labs Ltd and Lopinavir manufactured by Acebright (India) Pharma Pvt Ltd have been prequalified by the WHO Prequalification Team: medicines (PQTm) under its API pr
4 products newly prequalified
WHO Prequalification Team - Medicines (PQT) added the below new products to its prequalified list
WHO updates patent information on treatments for Hepatitis C
Visit the WHO website for updates on patent information on treatments for Hepatitis C
10th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health Medicines
The lack of prequalified reproductive health medicines is of great concern to WHO and to partner organizations working to improve reproductive health.